These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis. Tüter G, Kurtiş B, Serdar M. J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136 [Abstract] [Full Text] [Related]
5. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients. Alpagot T, Konopka K, Bhattacharyya M, Gebremedhin S, Düzgüneş N. J Periodontol; 2008 Jan; 79(1):123-30. PubMed ID: 18166101 [Abstract] [Full Text] [Related]
10. Effect of periodontal therapy on metabolic control and levels of IL-6 in the gingival crevicular fluid in type 2 diabetes mellitus. Camargo GA, Lima Mde A, Fortes TV, de Souza CS, de Jesus AM, de Almeida RP. Indian J Dent Res; 2013 May; 24(1):110-6. PubMed ID: 23852243 [Abstract] [Full Text] [Related]
11. Glycated albumin and calprotectin levels in gingival crevicular fluid from patients with periodontitis and type 2 diabetes. Kajiura Y, Bando M, Inagaki Y, Nagata T, Kido J. J Periodontol; 2014 Dec; 85(12):1667-75. PubMed ID: 25126693 [Abstract] [Full Text] [Related]
12. Resistin levels in gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus. Gokhale NH, Acharya AB, Patil VS, Trivedi DJ, Setty S, Thakur SL. J Periodontol; 2014 Apr; 85(4):610-7. PubMed ID: 23805816 [Abstract] [Full Text] [Related]
14. [Interleukin-1beta and IL-1 receptor antagonist levels in gingival crevicular fluid and their relationship to clinical indices of periodontitis]. Wu YF, Tan C, Zhang JY, Meng S, Guo YH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):683-6. PubMed ID: 15460419 [Abstract] [Full Text] [Related]
15. Effect of locally delivered minocycline microspheres on markers of bone resorption. Oringer RJ, Al-Shammari KF, Aldredge WA, Iacono VJ, Eber RM, Wang HL, Berwald B, Nejat R, Giannobile WV. J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491 [Abstract] [Full Text] [Related]
16. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis. Cetinkaya B, Guzeldemir E, Ogus E, Bulut S. J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257 [Abstract] [Full Text] [Related]
17. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases. Toyman U, Tüter G, Kurtiş B, Kıvrak E, Bozkurt Ş, Yücel AA, Serdar M. J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077 [Abstract] [Full Text] [Related]
18. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R. J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892 [Abstract] [Full Text] [Related]
19. Interleukin-1 beta levels in gingival crevicular fluid in type 2 diabetes mellitus and adult periodontitis. Bulut U, Develioglu H, Taner IL, Berker E. J Oral Sci; 2001 Sep; 43(3):171-7. PubMed ID: 11732737 [Abstract] [Full Text] [Related]
20. Correlation of levels of interleukin-1β in gingival crevicular fluid to the clinical parameters of chronic periodontitis. Chaudhari AU, Byakod GN, Waghmare PF, Karhadkar VM. J Contemp Dent Pract; 2011 Jan 01; 12(1):52-9. PubMed ID: 22186691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]